Skip to main content
SpringerLink
Log in

Cervical Squamous Intraepithelial Lesions

  • Chapter
  • First Online:
Pathology of the Cervix

Part of the book series: Essentials of Diagnostic Gynecological Pathology ((EDGP,volume 3))

  • 1345 Accesses

Abstract

Cervical squamous intraepithelial lesions [also known as cervical intraepithelial neoplasias (CINs), cervical dysplasias] impact a significant proportion of the population and are among the most commonly encountered diagnoses for the cytopathologist and surgical pathologist. Screening programs to detect and eradicate the subset of these lesions that are precancerous remain among the most impressive success stories in preventative medicine. Although many aspects of cervical neoplasia are familiar to all pathologists, this is a perpetually dynamic field due to changes in both technology and prevalence, leading to ongoing refinement of patient management. Recent decades have seen a rapid expansion in our understanding of cervical carcinogenesis leading to the development of new diagnostic biomarkers, novel testing assays, and effective vaccines. Screening strategies have also undergone renovation in response to these developments. This chapter reviews cervical squamous intraepithelial neoplasia from its earliest historical characterizations to its most up-to-date molecular underpinnings. It covers terminology, epidemiology, and screening techniques. Cytological and histological features are reviewed, as are morphological mimics. Finally, the molecular basis for disease is discussed with attention to potential immunohistochemical and molecular biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reagan JW, Hamonic MJ. The cellular pathology in carcinoma in situ; a cytohistopathological correlation. Cancer. 1956;9(2):385–402.

    Article  CAS  PubMed  Google Scholar 

  2. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann N Y Acad Sci. 1956;63(6):1245–61.

    Article  CAS  PubMed  Google Scholar 

  3. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. cytologic patterns. Acta Cytol. 1976;20(6):505–9.

    CAS  PubMed  Google Scholar 

  4. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix. II. cytologic, colposcopic and histopathologic study. Acta Cytol. 1977;21(3):379–90.

    CAS  PubMed  Google Scholar 

  5. Della Torre G, Pilotti S, de Palo G, Rilke F. Viral particles in cervical condylomatous lesions. Tumori. 1978;64(5):549–53.

    CAS  PubMed  Google Scholar 

  6. Hills E, Laverty CR. Electron microscopic detection of papilloma virus particles in selected koilocytotic cells in a routine cervical smear. Acta Cytol. 1979;23(1):53–6.

    CAS  PubMed  Google Scholar 

  7. Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol. 1969;105(3):386–93.

    Google Scholar 

  8. Richart RM. A theory of cervical carcinogenesis. Obstet Gynecol Surv. 1969;24(7 Pt 2):874–9.

    Article  CAS  PubMed  Google Scholar 

  9. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, Zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984;3(5):1151–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Crum CP, Ikenberg H, Richart RM, Gissman L. Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med. 1984;310(14):880–3.

    Google Scholar 

  11. Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30(Suppl 5):F55–70.

    Google Scholar 

  12. Darragh TM, Colgan TJ, Thomas Cox J, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the college of american pathologists and the american society for colposcopy and cervical pathology. Int J Gynecol Pathol. 2013;32(1):76–115.

    Google Scholar 

  13. Kurman RJ. International Agency for Research on Cancer, World Health Organization, WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014. p. 307.

    Google Scholar 

  14. Saslow D, Solomon D, Lawson HW, et al. American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516–42.

    Google Scholar 

  15. Peyton CL, Schiffman M, Lorincz AT, et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol. 1998;36(11):3248–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Siebers AG, Klinkhamer PJ, Grefte JM, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA. 2009;302(16):1757–64.

    Google Scholar 

  17. Bishop JW, Bigner SH, Colgan TJ, et al. Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. including initial biopsy results. Acta Cytol. 1998;42(1):189–97.

    Article  CAS  PubMed  Google Scholar 

  18. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008;111(1):167–77.

    Google Scholar 

  19. Stoler MH, Schiffman M, Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study. JAMA. 2001;285(11):1500–5.

    Google Scholar 

  20. Cinel A, Oselladore M, Insacco E, Minucci D. The accuracy of colposcopically directed biopsy in the diagnosis of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol. 1990;11(6):433–7.

    CAS  PubMed  Google Scholar 

  21. Guido RS, Jeronimo J, Schiffman M, Solomon D, ALTS Group. The distribution of neoplasia arising on the cervix: results from the ALTS trial. Am J Obstet Gynecol. 2005;193(4):1331–7.

    Google Scholar 

  22. Maniar KP, Sanchez B, Paintal A, Gursel DB, Nayar R. Role of the biomarker p16 in downgrading -IN 2 diagnoses and predicting higher-grade lesions. Am J Surg Pathol. 2015;39(12):1708–18.

    Google Scholar 

  23. Nayar R, Wilbur D. The bethesda system for reporting cervical cytology. Definitions, criteria, and explanatory notes. 3rd ed. Cham: Springer; 2015.

    Google Scholar 

  24. Symmans F, Mechanic L, MacConnell P, DaSilva K, Stricker B, Nuovo GJ. Correlation of cervical cytology and human papillomavirus DNA detection in postmenopausal women. Int J Gynecol Pathol. 1992;11(3):204–9.

    Article  CAS  PubMed  Google Scholar 

  25. Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010;34(8):1077–87.

    Google Scholar 

  26. Mills AM, Paquette C, Castle PE, Stoler MH. Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials. Am J Surg Pathol. 2015;39(5):611–7.

    Google Scholar 

  27. Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol. 2007;31(1):33–43.

    Google Scholar 

  28. Morgan TK, Berlin M. Immunocytochemical analysis of the cervical pap smear. Methods Mol Biol. 2015;1249:203–12.

    Google Scholar 

  29. Razmpoosh M, Sansregret A, Oligny LL, et al. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study. Am J Clin Pathol. 2014;142(1):104–10.

    Google Scholar 

  30. Carozzi F, Gillio-Tos A, Confortini M, et al. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial. Lancet Oncol. 2013;14(2):168–76.

    Google Scholar 

  31. Pacchiarotti A, Ferrari F, Bellardini P, et al. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study. Int J Cancer. 2014;134(4):897–904.

    Google Scholar 

  32. Sagasta A, Castillo P, Saco A, et al. P16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix. Mod Pathol. 2016;29(1):51–9.

    Google Scholar 

  33. Badr RE, Walts AE, Chung F, Bose SBD, ProEx C. A sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol. 2008;32(6):899–906.

    Google Scholar 

  34. Guo M, Baruch AC, Silva EG, et al. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Am J Clin Pathol. 2011;135(2):212–20.

    Google Scholar 

  35. Sanati S, Huettner P, Ylagan LR. Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens. Int J Gynecol Pathol. 2010;29(1):79–87.

    Google Scholar 

  36. Cabibi D, Giovannelli L, Martorana A, et al. Predictive role of histological features and Ki67 pattern on high-risk HPV presence in atypical cervical lesions. Histopathology. 2007;51(5):713–6.

    Google Scholar 

  37. Lee S, Sabourin J, Gage J, Franko A, Nation JG, Duggan MA. Squamous intraepithelial lesions in cervical tissue samples of limited adequacy and insufficient for grading as low or high grade: outcome, clinico-pathological correlates, and predictive role of p16INK4a and Ki67 biomarker staining. J Low Genit Tract Dis. 2015;19(1):35–45.

    Article  PubMed  Google Scholar 

  38. Kisser A, Zechmeister-Koss I. A systematic review of p16/ki-67 immuno-testing for triage of low grade cervical cytology. BJOG. 2015;122(1):64–70.

    Google Scholar 

  39. Herfs M, Yamamoto Y, Laury A, et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A. 2012;109(26):10516–21.

    Google Scholar 

  40. Herfs M, Parra-Herran C, Howitt BE, et al. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am J Surg Pathol. 2013;37(9):1311–8.

    Google Scholar 

  41. Paquette C, Mills AM, Stoler MH. Predictive value of cytokeratin 7 immunohistochemistry in cervical low-grade squamous intraepithelial lesion as a marker for risk of progression to a high-grade lesion. Am J Surg Pathol. 2016;40(2):236–43.

    Google Scholar 

  42. Selvi K, Badhe BA, Papa D, Ganesh RN. Role of p16, CK17, p63, and human papillomavirus in diagnosis of cervical intraepithelial neoplasia and distinction from its mimics. Int J Surg Pathol. 2014;22(3):221–30

    Google Scholar 

  43. Regauer S, Reich O. CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III). Histopathology. 2007;50(5):629–35.

    Google Scholar 

  44. Zhang W, Kapadia M, Sugarman M, et al. Adjunctive HPV in-situ hybridization (ISH) assay as an aid in the diagnosis of cervical intraepithelial neoplasia in cervical tissue specimens: an analytical and functional characterization. Int J Gynecol Pathol. 2012;31(6):588–95.

    Google Scholar 

  45. Evans MF, Peng Z, Clark KM, et al. HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade. PLoS One. 2014;9(3):e91142.

    Google Scholar 

  46. Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015;136(2):178–82.

    Google Scholar 

  47. Hopman AH, Smedts F, Dignef W, et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol. 2004;202(1):23–33.

    Google Scholar 

  48. Lu X, Lin Q, Lin M, et al. Multiple-integrations of HPV16 genome and altered transcription of viral oncogenes and cellular genes are associated with the development of cervical cancer. PLoS One. 2014;9(7):e97588.

    Google Scholar 

  49. Zhu D, Jiang XH, Jiang YH, et al. Amplification and overexpression of TP63 and MYC as biomarkers for transition of cervical intraepithelial neoplasia to cervical cancer. Int J Gynecol Cancer. 2014;24(4):643–8.

    Google Scholar 

  50. Kubler K, Heinenberg S, Rudlowski C, et al. C-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia. Oncotarget. 2015;6(2):825–35.

    Google Scholar 

  51. Hu B, Tao N, Zeng F, et al. A risk evaluation model of cervical cancer based on etiology and human leukocyte antigen allele susceptibility. Int J Infect Dis. 2014;28:8–12.

    Google Scholar 

  52. Matsumoto K, Maeda H, Oki A, et al. Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: at which step of multistage carcinogenesis? Cancer Sci. 2015;106(10):1448–54.

    Google Scholar 

  53. Klug SJ, Wilmotte R, Santos C, et al. TP53 polymorphism, HPV infection, and risk of cervical cancer. Cancer Epidemiol Biomarkers Prev. 2001;10(9):1009–12.

    CAS  PubMed  Google Scholar 

  54. Laprano TD, Lemos EH, Cunha LM, Junior JE, de SousaTeles RA, Rabenhorst SH. Association of TP53 codon 72 and intron 3 16-bp ins/del polymorphisms with cervical cancer risk. Tumour Biol. 2014;35(8):7435–40.

    Google Scholar 

  55. Katki HA, Gage JC, Schiffman M, et al. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less. J Low Genit Tract Dis. 2013;17(5 Suppl 1):S69–77.

    Google Scholar 

  56. Cox JT, Schiffman M, Solomon D, ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188(6):1406–12.

    Google Scholar 

  57. Bansal N, Wright JD, Cohen CJ, Herzog TJ. Natural history of established low grade cervical intraepithelial (CIN 1) lesions. Anticancer Res. 2008;28(3B):1763–6.

    PubMed  Google Scholar 

  58. Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30(Suppl 5):F123–38.

    Google Scholar 

  59. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425–34.

    Google Scholar 

  60. Miller ES, Sakowicz A, Grobman WA. The association between cervical dysplasia, a short cervix, and preterm birth. Am J Obstet Gynecol. 2015;213(4):543.e1–4.

    Google Scholar 

  61. Ciavattini A, Clemente N, Delli Carpini G, et al. Loop electrosurgical excision procedure and risk of miscarriage. Fertil Steril. 2015;103(4):1043–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Virginia Health System, Department of Pathology, Charlottesville, VA, USA

    Anne M. Mills & Mark H. Stoler

Authors
  1. Anne M. Mills
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark H. Stoler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark H. Stoler .

Editor information

Editors and Affiliations

  1. University of Edinburgh Edinburgh, Cancer Research Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, United Kingdom

    C. Simon Herrington

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Mills, A.M., Stoler, M.H. (2017). Cervical Squamous Intraepithelial Lesions. In: Herrington, C. (eds) Pathology of the Cervix. Essentials of Diagnostic Gynecological Pathology, vol 3. Springer, Cham. https://doi.org/10.1007/978-3-319-51257-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-51257-0_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-51255-6

  • Online ISBN: 978-3-319-51257-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation